Jorg Schulz, MD - Publications

Affiliations: 
Neurology Rheinisch-Westfaelische Technische Hochschule, Aachen, NRW, Germany 

165 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Jacobi H, du Montcel ST, Romanzetti S, Harmuth F, Mariotti C, Nanetti L, Rakowicz M, Makowicz G, Durr A, Monin ML, Filla A, Roca A, Schöls L, Hengel H, Infante J, ... ... Schulz JB, et al. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study. The Lancet. Neurology. 19: 738-747. PMID 32822634 DOI: 10.1016/S1474-4422(20)30235-0  0.4
2019 Reetz K, Hilgers RD, Isfort S, Dohmen M, Didszun C, Fedosov K, Kistermann J, Mariotti C, Durr A, Boesch S, Klopstock T, Rodríguez de Rivera Garrido FJ, Schöls L, Klockgether T, Pandolfo M, ... ... Schulz JB, et al. Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA). Neurological Research and Practice. 1: 33. PMID 33324899 DOI: 10.1186/s42466-019-0038-9  0.4
2019 Hohenfeld C, Dogan I, Schubert R, Didszun C, Schöls L, Synofzik M, Giordano IA, Klockgether T, Schulz JB, Reilmann R, Reetz K. Application of Quantitative Motor Assessments in Friedreich Ataxia and Evaluation of Their Relation to Clinical Measures. Cerebellum (London, England). PMID 31441004 DOI: 10.1007/S12311-019-01073-X  0.4
2019 Diallo A, Jacobi H, Cook A, Giunti P, Parkinson MH, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Castaldo A, Rakowicz M, ... ... Schulz JB, et al. Prediction of Survival With Long-Term Disease Progression in Most Common Spinocerebellar Ataxia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31211461 DOI: 10.1002/mds.27739  0.4
2019 Hopfner F, Müller SH, Steppat D, Miller J, Schmidt N, Wandinger KP, Leypoldt F, Berg D, Franke A, Lieb W, Tittmann L, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Hilker-Roggendorf R, ... ... Schulz JB, et al. No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors. Translational Neurodegeneration. 8: 11. PMID 30984390 DOI: 10.1186/S40035-019-0153-0  0.4
2018 Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R, Parkinson MH, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Sarro L, Rakowicz M, ... ... Schulz JB, et al. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias. Journal of Neurology. PMID 29959555 DOI: 10.1007/s00415-018-8954-0  0.4
2018 Dogan I, Romanzetti S, Didszun C, Mirzazade S, Timmann D, Saft C, Schöls L, Synofzik M, Giordano IA, Klockgether T, Schulz JB, Reetz K. Structural characteristics of the central nervous system in Friedreich ataxia: an in vivo spinal cord and brain MRI study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29945881 DOI: 10.1136/jnnp-2018-318422  0.4
2018 Diallo A, Jacobi H, Cook A, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, Sobanska A, Sulek A, Schmitz-Hübsch T, ... ... Schulz JB, et al. Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study. The Lancet. Neurology. 17: 327-334. PMID 29553382 DOI: 10.1016/S1474-4422(18)30042-5  0.4
2017 Diallo A, Jacobi H, Schmitz-Hübsch T, Cook A, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, Sobanska A, Sulek A, ... ... Schulz JB, et al. Body Mass Index Decline Is Related to Spinocerebellar Ataxia Disease Progression. Movement Disorders Clinical Practice. 4: 689-697. PMID 30363449 DOI: 10.1002/mdc3.12522  0.4
2017 Tanguy Melac A, Mariotti C, Filipovic Pierucci A, Giunti P, Arpa J, Boesch S, Klopstock T, Müller Vom Hagen J, Klockgether T, Bürk K, Schulz JB, Reetz K, Pandolfo M, Durr A, Tezenas du Montcel S, et al. Friedreich and dominant ataxias: quantitative differences in cerebellar dysfunction measurements. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29279305 DOI: 10.1136/jnnp-2017-316964  0.4
2016 Paap BK, Roeske S, Durr A, Schöls L, Ashizawa T, Boesch S, Bunn LM, Delatycki MB, Giunti P, Lehéricy S, Mariotti C, Melegh J, Pandolfo M, Tallaksen CME, Timmann D, ... ... Schulz JB, et al. Standardized Assessment of Hereditary Ataxia Patients in Clinical Studies. Movement Disorders Clinical Practice. 3: 230-240. PMID 30363623 DOI: 10.1002/Mdc3.12315  0.4
2016 Reetz K, Dogan I, Hilgers RD, Giunti P, Mariotti C, Durr A, Boesch S, Klopstock T, de Rivera FJ, Schöls L, Klockgether T, Bürk K, Rai M, Pandolfo M, Schulz JB, et al. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study. The Lancet. Neurology. 15: 1346-1354. PMID 27839651 DOI: 10.1016/S1474-4422(16)30287-3  0.4
2016 Dogan I, Tinnemann E, Romanzetti S, Mirzazade S, Costa AS, Werner CJ, Heim S, Fedosov K, Schulz S, Timmann D, Giordano IA, Klockgether T, Schulz JB, Reetz K. Cognition in Friedreich's ataxia: a behavioral and multimodal imaging study. Annals of Clinical and Translational Neurology. 3: 572-87. PMID 27606341 DOI: 10.1002/acn3.315  0.4
2016 Vingill S, Brockelt D, Lancelin C, Tatenhorst L, Dontcheva G, Preisinger C, Schwedhelm-Domeyer N, Joseph S, Mitkovski M, Goebbels S, Nave KA, Schulz JB, Marquardt T, Lingor P, Stegmüller J. Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice. The Embo Journal. PMID 27497298 DOI: 10.15252/Embj.201593585  0.88
2016 Mengel D, Dams J, Ziemek J, Becker J, Balzer-Geldsetzer M, Hilker R, Baudrexel S, Kalbe E, Schmidt N, Witt K, Liepelt-Scarfone I, Gräber S, Petrelli A, Neuser P, Schulte C, ... ... Schulz JB, et al. Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease. Parkinsonism & Related Disorders. PMID 27321987 DOI: 10.1016/j.parkreldis.2016.04.013  0.88
2016 Park Y, Kyo Jung J, Kim Y. A Mixture of Bacillus thuringiensis subsp. israelensis With Xenorhabdus nematophila-Cultured Broth Enhances Toxicity Against Mosquitoes Aedes albopictus and Culex pipiens pallens (Diptera: Culicidae). Journal of Economic Entomology. PMID 27018440 DOI: 10.1093/jee/tow063  0.52
2016 Schürmann K, Nikoubashman O, Falkenburger B, Tauber SC, Wiesmann M, Schulz JB, Reich A. Risk profile and treatment options of acute ischemic in-hospital stroke. Journal of Neurology. PMID 26762395 DOI: 10.1007/s00415-015-8010-2  0.88
2016 Nikoubashman O, Jungbluth M, Schürmann K, Müller M, Falkenburger B, Tauber SC, Wiesmann M, Schulz JB, Reich A. Neurothrombectomy in acute ischaemic stroke: A prospective single-centre study and comparison with randomized controlled trials European Journal of Neurology. 23: 807-816. DOI: 10.1111/ene.12944  0.88
2016 Werheid F, Azzedine H, Zwerenz E, Bozkurt A, Moeller MJ, Lin L, Mull M, Häusler M, Schulz JB, Weis J, Claeys KG. Underestimated associated features in CMT neuropathies: Clinical indicators for the causative gene? Brain and Behavior. DOI: 10.1002/brb3.451  0.88
2015 Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R, Parkinson MH, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, ... ... Schulz JB, et al. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. The Lancet. Neurology. 14: 1101-8. PMID 26377379 DOI: 10.1016/S1474-4422(15)00202-1  0.88
2015 Dogan I, Eickhoff CR, Fox PT, Laird AR, Schulz JB, Eickhoff SB, Reetz K. Functional connectivity modeling of consistent cortico-striatal degeneration in Huntington's disease. Neuroimage. Clinical. 7: 640-52. PMID 25844318 DOI: 10.1016/J.Nicl.2015.02.018  0.88
2015 Reetz K, Abbas Z, Costa AS, Gras V, Tiffin-Richards F, Mirzazade S, Holschbach B, Frank RD, Vassiliadou A, Krüger T, Eitner F, Gross T, Schulz JB, Floege J, Shah NJ. Increased cerebral water content in hemodialysis patients. Plos One. 10: e0122188. PMID 25826269 DOI: 10.1371/journal.pone.0122188  0.88
2015 Filipovic Pierucci A, Mariotti C, Panzeri M, Giunti P, Boesch S, Schulz JB, Pandolfo M, Durr A, Tezenas du Montcel S. Quantifiable evaluation of cerebellar signs in children. Neurology. 84: 1225-32. PMID 25716360 DOI: 10.1212/WNL.0000000000001403  0.88
2015 Dohrn MF, Othman A, Hirshman SK, Bode H, Alecu I, Fähndrich E, Karges W, Weis J, Schulz JB, Hornemann T, Claeys KG. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy? European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 22: 806-14, e55. PMID 25623782 DOI: 10.1111/ene.12663  0.88
2015 Reetz K, Dogan I, Costa AS, Dafotakis M, Fedosov K, Giunti P, Parkinson MH, Sweeney MG, Mariotti C, Panzeri M, Nanetti L, Arpa J, Sanz-Gallego I, Durr A, Charles P, ... ... Schulz JB, et al. Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data. The Lancet. Neurology. 14: 174-82. PMID 25566998 DOI: 10.1016/S1474-4422(14)70321-7  0.88
2015 Schmidt AK, Reich A, Falkenburger B, Schulz JB, Brandenburg LO, Ribes S, Tauber SC. Adjuvant granulocyte colony-stimulating factor therapy results in improved spatial learning and stimulates hippocampal neurogenesis in a mouse model of pneumococcal meningitis. Journal of Neuropathology and Experimental Neurology. 74: 85-94. PMID 25470346 DOI: 10.1097/NEN.0000000000000152  0.88
2015 Matz O, Litmathe J, Schiefer J, Lehmann M, Schulz JB, Dafotakis M. Hypercapnia-Induced Artificial Respiration Following a Subacute Axonal Sensorimotor Polyneuropathy Staining Positive for SOX-1 | CO2-induzierte Beatmungspflichtigkeit aufgrund einer SOX1-Antikörper-positiven subakuten axonal-betonten sensomotorische Polyneuropathie Klinische Neurophysiologie. 46: 158-160. DOI: 10.1055/s-0035-1552693  0.88
2014 Semmler AL, Sacconi S, Bach JE, Liebe C, Bürmann J, Kley RA, Ferbert A, Anderheiden R, Van den Bergh P, Martin JJ, De Jonghe P, Neuen-Jacob E, Müller O, Deschauer M, Bergmann M, ... ... Schulz JB, et al. Unusual multisystemic involvement and a novel BAG3 mutation revealed by NGS screening in a large cohort of myofibrillar myopathies. Orphanet Journal of Rare Diseases. 9: 121. PMID 25208129 DOI: 10.1186/s13023-014-0121-9  0.88
2014 Bozkurt A, van Neerven SG, Claeys KG, O'Dey DM, Sudhoff A, Brook GA, Sellhaus B, Schulz JB, Weis J, Pallua N. The proximal medial sural nerve biopsy model: a standardised and reproducible baseline clinical model for the translational evaluation of bioengineered nerve guides. Biomed Research International. 2014: 121452. PMID 25006574 DOI: 10.1155/2014/121452  0.88
2014 Ketteler S, Ketteler D, Vohn R, Kastrau F, Schulz JB, Reetz K, Huber W. The processing of lexical ambiguity in healthy ageing and Parkinson׳s disease: role of cortico-subcortical networks. Brain Research. 1581: 51-63. PMID 24992291 DOI: 10.1016/J.Brainres.2014.06.030  0.88
2014 Hans F, Fiesel FC, Strong JC, Jäckel S, Rasse TM, Geisler S, Springer W, Schulz JB, Voigt A, Kahle PJ. UBE2E ubiquitin-conjugating enzymes and ubiquitin isopeptidase Y regulate TDP-43 protein ubiquitination. The Journal of Biological Chemistry. 289: 19164-79. PMID 24825905 DOI: 10.1074/Jbc.M114.561704  0.88
2014 Tauber SC, Harms K, Falkenburger B, Weis J, Sellhaus B, Nau R, Schulz JB, Reich A. Modulation of hippocampal neuroplasticity by Fas/CD95 regulatory protein 2 (Faim2) in the course of bacterial meningitis. Journal of Neuropathology and Experimental Neurology. 73: 2-13. PMID 24335530 DOI: 10.1097/NEN.0000000000000020  0.88
2014 Nikoubashman O, Reich A, Gindullis M, Frohnhofen K, Pjontek R, Brockmann MA, Schulz JB, Wiesmann M. Clinical significance of post-interventional cerebral hyperdensities after endovascular mechanical thrombectomy in acute ischaemic stroke. Neuroradiology. 56: 41-50. PMID 24306553 DOI: 10.1007/s00234-013-1303-1  0.88
2014 Schreckenbach T, Schröder JM, Voit T, Abicht A, Neuen-Jacob E, Roos A, Bulst S, Kuhl C, Schulz JB, Weis J, Claeys KG. Novel TPM3 mutation in a family with cap myopathy and review of the literature. Neuromuscular Disorders : Nmd. 24: 117-24. PMID 24239060 DOI: 10.1016/j.nmd.2013.10.002  0.88
2014 Costa AS, Reich A, Fimm B, Ketteler ST, Schulz JB, Reetz K. Evidence of the sensitivity of the MoCA alternate forms in monitoring cognitive change in early Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 37: 95-103. PMID 24107412 DOI: 10.1159/000351864  0.88
2014 Dogan I, Saß C, Mirzazade S, Kleiman A, Werner CJ, Pohl A, Schiefer J, Binkofski F, Schulz JB, Shah NJ, Reetz K. Neural correlates of impaired emotion processing in manifest Huntington's disease. Social Cognitive and Affective Neuroscience. 9: 671-80. PMID 23482620 DOI: 10.1093/Scan/Nst029  0.88
2014 Dafotakis M, Nikoubashman O, Rattay T, Eickhoff SB, Reich A, Schulz JB, Schiefer J. The Role of Cranial Computed Tomography in the Diagnosis of Acute Facial Nerve Paralysis | Die Wertigkeit der zerebralen Computertomografie bei der Differenzialdiagnostik der akuten peripheren Fazialisparese Klinische Neurophysiologie. 45: 164-167. DOI: 10.1055/S-0034-1382073  0.88
2013 Williams SR, Hausmann L, Schulz JB. Molecular imaging and its applications: visualization beyond imagination. Journal of Neurochemistry. 127: 575-7. PMID 24730027 DOI: 10.1111/jnc.12445  0.88
2013 Ghosh A, Kling T, Snaidero N, Sampaio JL, Shevchenko A, Gras H, Geurten B, Göpfert MC, Schulz JB, Voigt A, Simons M. A global in vivo Drosophila RNAi screen identifies a key role of ceramide phosphoethanolamine for glial ensheathment of axons. Plos Genetics. 9: e1003980. PMID 24348263 DOI: 10.1371/Journal.Pgen.1003980  0.88
2013 Ketteler S, Djalali-Talab Y, Dafotakis M, Wiesmann M, Schulz JB, Haarmeier T. Teaching neuroimages: combined retinal and cerebral hyperperfusion syndrome after carotid thromboendarterectomy. Neurology. 81: e166-7. PMID 24276341 DOI: 10.1212/01.Wnl.0000436608.43457.0D  0.88
2013 Dohrn MF, Röcken C, De Bleecker JL, Martin JJ, Vorgerd M, Van den Bergh PY, Ferbert A, Hinderhofer K, Schröder JM, Weis J, Schulz JB, Claeys KG. Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy. Journal of Neurology. 260: 3093-108. PMID 24101130 DOI: 10.1007/s00415-013-7124-7  0.88
2013 Lenz S, Karsten P, Schulz JB, Voigt A. Drosophila as a screening tool to study human neurodegenerative diseases. Journal of Neurochemistry. 127: 453-60. PMID 24028575 DOI: 10.1111/jnc.12446  0.88
2013 Claeys KG, Gorodinskaya O, Handt S, Reimann J, Kress W, Kornblum C, Kuhl C, Schulz JB, Weis J. Diagnostic challenge and therapeutic dilemma in necrotizing myopathy. Neurology. 81: 932-5. PMID 23921885 DOI: 10.1212/WNL.0b013e3182a35285  0.88
2013 Jacobi H, Reetz K, du Montcel ST, Bauer P, Mariotti C, Nanetti L, Rakowicz M, Sulek A, Durr A, Charles P, Filla A, Antenora A, Schöls L, Schicks J, Infante J, ... ... Schulz JB, et al. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. The Lancet. Neurology. 12: 650-8. PMID 23707147 DOI: 10.1016/S1474-4422(13)70104-2  0.4
2013 Funk F, Ceuterick-de Groote C, Martin JJ, Meinhardt A, Taratuto AL, De Bleecker J, Van Coster R, De Paepe B, Schara U, Vorgerd M, Häusler M, Koppi S, Maschke M, De Jonghe P, Van Maldergem L, ... ... Schulz JB, et al. Morphological spectrum and clinical features of myopathies with tubular aggregates. Histology and Histopathology. 28: 1041-54. PMID 23479431  0.88
2013 Reetz K, Costa AS, Mirzazade S, Lehmann A, Juzek A, Rakowicz M, Boguslawska R, Schöls L, Linnemann C, Mariotti C, Grisoli M, Dürr A, van de Warrenburg BP, Timmann D, Pandolfo M, ... ... Schulz JB, et al. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain : a Journal of Neurology. 136: 905-17. PMID 23423669 DOI: 10.1093/brain/aws369  0.4
2013 Metz G, Coppard N, Cooper JM, Delatycki MB, Dürr A, Di Prospero NA, Giunti P, Lynch DR, Schulz JB, Rummey C, Meier T. Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database. Brain : a Journal of Neurology. 136: 259-68. PMID 23365101 DOI: 10.1093/Brain/Aws309  0.88
2013 Lynch DR, Pandolfo M, Schulz JB, Perlman S, Delatycki MB, Payne RM, Shaddy R, Fischbeck KH, Farmer J, Kantor P, Raman SV, Hunegs L, Odenkirchen J, Miller K, Kaufmann P. Common data elements for clinical research in Friedreich's ataxia. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 190-5. PMID 23239403 DOI: 10.1002/Mds.25201  0.88
2013 Rottschy C, Caspers S, Roski C, Reetz K, Dogan I, Schulz JB, Zilles K, Laird AR, Fox PT, Eickhoff SB. Differentiated parietal connectivity of frontal regions for "what" and "where" memory. Brain Structure & Function. 218: 1551-67. PMID 23143344 DOI: 10.1007/S00429-012-0476-4  0.88
2013 Dogan I, Eickhoff SB, Schulz JB, Shah NJ, Laird AR, Fox PT, Reetz K. Consistent neurodegeneration and its association with clinical progression in Huntington's disease: a coordinate-based meta-analysis. Neuro-Degenerative Diseases. 12: 23-35. PMID 22922585 DOI: 10.1159/000339528  0.88
2013 Szeg? ÉM, Outeiro TF, Kermer P, Schulz JB. Impairment of the septal cholinergic neurons in MPTP-treated A30P α-synuclein mice. Neurobiology of Aging. 34: 589-601. PMID 22579457 DOI: 10.1016/J.Neurobiolaging.2012.04.012  0.88
2012 Claeys KG, Schrading S, Bozkurt A, Friedrich-Freksa A, Pallua N, Kuhl C, Schulz JB, Weis J. Myopathy with lobulated fibers, cores, and rods caused by a mutation in collagen VI. Neurology. 79: 2288-90. PMID 23175733 DOI: 10.1212/WNL.0b013e31827689fb  0.88
2012 VoSSfeldt H, Butzlaff M, PrüSSing K, Ní Chárthaigh RA, Karsten P, Lankes A, Hamm S, Simons M, Adryan B, Schulz JB, Voigt A. Large-scale screen for modifiers of ataxin-3-derived polyglutamine-induced toxicity in Drosophila. Plos One. 7: e47452. PMID 23139745 DOI: 10.1371/Journal.Pone.0047452  0.88
2012 Costa AS, Fimm B, Friesen P, Soundjock H, Rottschy C, Gross T, Eitner F, Reich A, Schulz JB, Nasreddine ZS, Reetz K. Alternate-form reliability of the Montreal cognitive assessment screening test in a clinical setting. Dementia and Geriatric Cognitive Disorders. 33: 379-84. PMID 22797211 DOI: 10.1159/000340006  0.88
2012 Beier CP, Kumar P, Meyer K, Leukel P, Bruttel V, Aschenbrenner I, Riemenschneider MJ, Fragoulis A, Rümmele P, Lamszus K, Schulz JB, Weis J, Bogdahn U, Wischhusen J, Hau P, et al. The cancer stem cell subtype determines immune infiltration of glioblastoma. Stem Cells and Development. 21: 2753-61. PMID 22676416 DOI: 10.1089/Scd.2011.0660  0.88
2012 Reetz K, Dogan I, Rolfs A, Binkofski F, Schulz JB, Laird AR, Fox PT, Eickhoff SB. Investigating function and connectivity of morphometric findings--exemplified on cerebellar atrophy in spinocerebellar ataxia 17 (SCA17). Neuroimage. 62: 1354-66. PMID 22659444 DOI: 10.1016/J.Neuroimage.2012.05.058  0.88
2012 Bergrath S, Reich A, Rossaint R, Rörtgen D, Gerber J, Fischermann H, Beckers SK, Brokmann JC, Schulz JB, Leber C, Fitzner C, Skorning M. Feasibility of prehospital teleconsultation in acute stroke--a pilot study in clinical routine. Plos One. 7: e36796. PMID 22629331 DOI: 10.1371/journal.pone.0036796  0.88
2012 Butler EK, Voigt A, Lutz AK, Toegel JP, Gerhardt E, Karsten P, Falkenburger B, Reinartz A, Winklhofer KF, Schulz JB. The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity. Plos Genetics. 8: e1002488. PMID 22319455 DOI: 10.1371/journal.pgen.1002488  0.88
2012 Rottschy C, Langner R, Dogan I, Reetz K, Laird AR, Schulz JB, Fox PT, Eickhoff SB. Modelling neural correlates of working memory: a coordinate-based meta-analysis. Neuroimage. 60: 830-46. PMID 22178808 DOI: 10.1016/J.Neuroimage.2011.11.050  0.88
2012 Jacobi H, Hauser TK, Giunti P, Globas C, Bauer P, Schmitz-Hübsch T, Baliko L, Filla A, Mariotti C, Rakowicz M, Charles P, Ribai P, Szymanski S, Infante J, van de Warrenburg BP, ... ... Schulz JB, et al. Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings. Cerebellum (London, England). 11: 155-66. PMID 21701895 DOI: 10.1007/S12311-011-0292-Z  0.88
2012 Nickl-Jockschat T, Kleiman A, Schulz JB, Schneider F, Laird AR, Fox PT, Eickhoff SB, Reetz K. Neuroanatomic changes and their association with cognitive decline in mild cognitive impairment: a meta-analysis. Brain Structure & Function. 217: 115-25. PMID 21667303 DOI: 10.1007/S00429-011-0333-X  0.88
2011 Balzer-Geldsetzer M, Costa AS, Kronenbürger M, Schulz JB, Röske S, Spottke A, Wüllner U, Klockgether T, Storch A, Schneider C, Riedel O, Wittchen HU, Seifried C, Hilker R, Schmidt N, et al. Parkinson's disease and dementia: a longitudinal study (DEMPARK). Neuroepidemiology. 37: 168-76. PMID 22067139 DOI: 10.1159/000331490  0.88
2011 Jacobi H, Bauer P, Giunti P, Labrum R, Sweeney MG, Charles P, Dürr A, Marelli C, Globas C, Linnemann C, Schöls L, Rakowicz M, Rola R, Zdzienicka E, Schmitz-Hübsch T, ... ... Schulz J, et al. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology. 77: 1035-41. PMID 21832228 DOI: 10.1212/Wnl.0B013E31822E7Ca0  0.4
2011 Schmitz-Hübsch T, Coudert M, Tezenas du Montcel S, Giunti P, Labrum R, Dürr A, Ribai P, Charles P, Linnemann C, Schöls L, Rakowicz M, Rola R, Zdzienicka E, Fancellu R, Mariotti C, ... ... Schulz JB, et al. Depression comorbidity in spinocerebellar ataxia. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 870-6. PMID 21437988 DOI: 10.1002/Mds.23698  0.4
2011 Reich A, Spering C, Gertz K, Harms C, Gerhardt E, Kronenberg G, Nave KA, Schwab M, Tauber SC, Drinkut A, Harms K, Beier CP, Voigt A, Göbbels S, Endres M, ... Schulz JB, et al. Fas/CD95 regulatory protein Faim2 is neuroprotective after transient brain ischemia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 225-33. PMID 21209208 DOI: 10.1523/JNEUROSCI.2188-10.2011  0.88
2011 Reich A, Schulz JB. Update: Alzheimers disease | Neues zur Alzheimer Erkrankung Aktuelle Neurologie. 38: 234-241. DOI: 10.1055/s-0031-1285838  0.88
2010 Voigt A, Herholz D, Fiesel FC, Kaur K, Müller D, Karsten P, Weber SS, Kahle PJ, Marquardt T, Schulz JB. TDP-43-mediated neuron loss in vivo requires RNA-binding activity. Plos One. 5: e12247. PMID 20806063 DOI: 10.1371/journal.pone.0012247  0.88
2010 Zobel S, Hummel T, Ilgner J, Finkelmeyer A, Habel U, Timmann D, Schulz JB, Kronenbuerger M. Involvement of the human ventrolateral thalamus in olfaction. Journal of Neurology. 257: 2037-43. PMID 20640578 DOI: 10.1007/S00415-010-5656-7  0.88
2010 Süssmuth SD, Uttner I, Landwehrmeyer B, Pinkhardt EH, Brettschneider J, Petzold A, Kramer B, Schulz JB, Palm C, Otto M, Ludolph AC, Kassubek J, Tumani H. Differential pattern of brain-specific CSF proteins tau and amyloid-β in Parkinsonian syndromes. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1284-8. PMID 20589870 DOI: 10.1002/mds.22895  0.88
2010 Schmitz-Hübsch T, Fimmers R, Rakowicz M, Rola R, Zdzienicka E, Fancellu R, Mariotti C, Linnemann C, Schöls L, Timmann D, Filla A, Salvatore E, Infante J, Giunti P, Labrum R, ... ... Schulz J, et al. Responsiveness of different rating instruments in spinocerebellar ataxia patients. Neurology. 74: 678-84. PMID 20177122 DOI: 10.1212/Wnl.0B013E3181D1A6C9  0.88
2010 Schmitz-Hübsch T, Coudert M, Giunti P, Globas C, Baliko L, Fancellu R, Mariotti C, Filla A, Rakowicz M, Charles P, Ribai P, Szymanski S, Infante J, van de Warrenburg BP, Dürr A, ... ... Schulz JB, et al. Self-rated health status in spinocerebellar ataxia--results from a European multicenter study. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 587-95. PMID 20175183 DOI: 10.1002/Mds.22740  0.88
2010 Kronenbuerger M, Zobel S, Ilgner J, Finkelmeyer A, Reinacher P, Coenen VA, Wilms H, Kloss M, Kiening K, Daniels C, Falk D, Schulz JB, Deuschl G, Hummel T. Effects of deep brain stimulation of the cerebellothalamic pathways on the sense of smell. Experimental Neurology. 222: 144-52. PMID 20051243 DOI: 10.1016/J.Expneurol.2009.12.024  0.88
2010 Fiesel FC, Voigt A, Weber SS, Van den Haute C, Waldenmaier A, Görner K, Walter M, Anderson ML, Kern JV, Rasse TM, Schmidt T, Springer W, Kirchner R, Bonin M, Neumann M, ... ... Schulz JB, et al. Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. The Embo Journal. 29: 209-21. PMID 19910924 DOI: 10.1038/Emboj.2009.324  0.88
2010 Nuber S, Franck T, Wolburg H, Schumann U, Casadei N, Fischer K, Calaminus C, Pichler BJ, Chanarat S, Teismann P, Schulz JB, Luft AR, Tomiuk J, Wilbertz J, Bornemann A, et al. Transgenic overexpression of the alpha-synuclein interacting protein synphilin-1 leads to behavioral and neuropathological alterations in mice. Neurogenetics. 11: 107-20. PMID 19760259 DOI: 10.1007/s10048-009-0212-2  0.88
2010 Schulz JB, Borkert J, Wolf S, Schmitz-Hübsch T, Rakowicz M, Mariotti C, Schöls L, Schoels L, Timmann D, van de Warrenburg B, Dürr A, Pandolfo M, Kang JS, Mandly AG, Nägele T, et al. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. Neuroimage. 49: 158-68. PMID 19631275 DOI: 10.1016/j.neuroimage.2009.07.027  0.4
2009 Bürk K, Mälzig U, Wolf S, Heck S, Dimitriadis K, Schmitz-Hübsch T, Hering S, Lindig TM, Haug V, Timmann D, Degen I, Kruse B, Dörr JM, Ratzka S, Ivo A, ... ... Schulz JB, et al. Comparison of three clinical rating scales in Friedreich ataxia (FRDA). Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1779-84. PMID 19562766 DOI: 10.1002/mds.22660  0.4
2009 Schulz JB, Di Prospero NA, Fischbeck K. Clinical experience with high-dose idebenone in Friedreich ataxia. Journal of Neurology. 256: 42-5. PMID 19283350 DOI: 10.1007/s00415-009-1008-x  0.88
2008 Dodel R, Csoti I, Ebersbach G, Fuchs G, Hahne M, Kuhn W, Oechsner M, Jost W, Reichmann H, Schulz JB. Lewy body dementia and Parkinson's disease with dementia. Journal of Neurology. 255: 39-47. PMID 18787881 DOI: 10.1007/s00415-008-5007-0  0.88
2008 Nuber S, Petrasch-Parwez E, Winner B, Winkler J, von Hörsten S, Schmidt T, Boy J, Kuhn M, Nguyen HP, Teismann P, Schulz JB, Neumann M, Pichler BJ, Reischl G, Holzmann C, et al. Neurodegeneration and motor dysfunction in a conditional model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 2471-84. PMID 18322092 DOI: 10.1523/JNEUROSCI.3040-07.2008  0.88
2008 Dietz GP, Stockhausen KV, Dietz B, Falkenburger BH, Valbuena P, Opazo F, Lingor P, Meuer K, Weishaupt JH, Schulz JB, Bähr M. Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigra. Journal of Neurochemistry. 104: 757-65. PMID 17995935 DOI: 10.1111/J.1471-4159.2007.05028.X  0.88
2007 Kowsky S, Pöppelmeyer C, Kramer ER, Falkenburger BH, Kruse A, Klein R, Schulz JB. RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals. Proceedings of the National Academy of Sciences of the United States of America. 104: 20049-54. PMID 18056810 DOI: 10.1073/Pnas.0706177104  0.88
2007 Perier C, Bové J, Wu DC, Dehay B, Choi DK, Jackson-Lewis V, Rathke-Hartlieb S, Bouillet P, Strasser A, Schulz JB, Przedborski S, Vila M. Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 104: 8161-6. PMID 17483459 DOI: 10.1073/Pnas.0609874104  0.88
2006 Hauser TK, Luft A, Skalej M, Nägele T, Kircher TT, Leube DT, Schulz JB. Visualization and quantification of disease progression in multiple system atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1674-81. PMID 16830312 DOI: 10.1002/Mds.21032  0.88
2006 Gröschel K, Kastrup A, Litvan I, Schulz JB. Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy. Neurology. 66: 949-50. PMID 16567726 DOI: 10.1212/01.Wnl.0000203342.77115.Bf  0.88
2006 Minich T, Riemer J, Schulz JB, Wielinga P, Wijnholds J, Dringen R. The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes. Journal of Neurochemistry. 97: 373-84. PMID 16539673 DOI: 10.1111/J.1471-4159.2006.03737.X  0.88
2005 McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, ... ... Schulz JB, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 65: 1863-72. PMID 16237129 DOI: 10.1212/01.Wnl.0000187889.17253.B1  0.88
2005 Beier CP, Wischhusen J, Gleichmann M, Gerhardt E, Pekanovic A, Krueger A, Taylor V, Suter U, Krammer PH, Endres M, Weller M, Schulz JB. FasL (CD95L/APO-1L) resistance of neurons mediated by phosphatidylinositol 3-kinase-Akt/protein kinase B-dependent expression of lifeguard/neuronal membrane protein 35. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 6765-74. PMID 16033886 DOI: 10.1523/Jneurosci.1700-05.2005  0.88
2005 Bürk K, Bühring U, Schulz JB, Zühlke C, Hellenbroich Y, Dichgans J. Clinical and magnetic resonance imaging characteristics of sporadic cerebellar ataxia. Archives of Neurology. 62: 981-5. PMID 15956170 DOI: 10.1001/archneur.62.6.981  0.88
2005 Schneider A, Länder H, Schulz G, Wolburg H, Nave KA, Schulz JB, Simons M. Palmitoylation is a sorting determinant for transport to the myelin membrane. Journal of Cell Science. 118: 2415-23. PMID 15923654 DOI: 10.1242/Jcs.02365  0.88
2005 Schulz JB, Benecke R, Dodel R, Eggert K, Fogel W, Gerlach M, Reichmann H, Riederer P, Schwartz A, Winkler J. Stepwise diagnostics for Parkinsonian syndromes | Strukturierte diagnostik bei Parkinson-syndromen Aktuelle Neurologie, Supplement. 32: S97-S101. DOI: 10.1055/S-2005-866880  0.88
2004 Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Morcos M, Sayed AA, Andrassy M, Schiekofer S, Schneider JG, Schulz JB, Heuss D, Neundörfer B, Dierl S, Huber J, et al. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. The Journal of Clinical Investigation. 114: 1741-51. PMID 15599399 DOI: 10.1172/JCI18058  0.88
2004 Luft AR, McCombe-Waller S, Whitall J, Forrester LW, Macko R, Sorkin JD, Schulz JB, Goldberg AP, Hanley DF. Repetitive bilateral arm training and motor cortex activation in chronic stroke: a randomized controlled trial. Jama. 292: 1853-61. PMID 15494583 DOI: 10.1001/Jama.292.15.1853  0.88
2004 Buitrago MM, Ringer T, Schulz JB, Dichgans J, Luft AR. Characterization of motor skill and instrumental learning time scales in a skilled reaching task in rat. Behavioural Brain Research. 155: 249-56. PMID 15364484 DOI: 10.1016/j.bbr.2004.04.025  0.88
2004 Luft AR, Buitrago MM, Kaelin-Lang A, Dichgans J, Schulz JB. Protein synthesis inhibition blocks consolidation of an acrobatic motor skill. Learning & Memory (Cold Spring Harbor, N.Y.). 11: 379-82. PMID 15286180 DOI: 10.1101/lm.72604  0.88
2004 Luft AR, Buitrago MM, Ringer T, Dichgans J, Schulz JB. Motor skill learning depends on protein synthesis in motor cortex after training. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 6515-20. PMID 15269262 DOI: 10.1523/JNEUROSCI.1034-04.2004  0.88
2004 Buitrago MM, Schulz JB, Dichgans J, Luft AR. Short and long-term motor skill learning in an accelerated rotarod training paradigm. Neurobiology of Learning and Memory. 81: 211-6. PMID 15082022 DOI: 10.1016/j.nlm.2004.01.001  0.88
2004 Schneider D, Gerhardt E, Bock J, Müller MM, Wolburg H, Lang F, Schulz JB. Intracellular acidification by inhibition of the Na+/H+-exchanger leads to caspase-independent death of cerebellar granule neurons resembling paraptosis. Cell Death and Differentiation. 11: 760-70. PMID 15017383 DOI: 10.1038/Sj.Cdd.4401377  0.88
2004 Luft AR, Waller S, Forrester L, Smith GV, Whitall J, Macko RF, Schulz JB, Hanley DF. Lesion location alters brain activation in chronically impaired stroke survivors. Neuroimage. 21: 924-35. PMID 15006659 DOI: 10.1016/J.Neuroimage.2003.10.026  0.88
2004 Gröschel K, Hauser TK, Luft A, Patronas N, Dichgans J, Litvan I, Schulz JB. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage. 21: 714-24. PMID 14980574 DOI: 10.1016/J.Neuroimage.2003.09.070  0.88
2004 Moreira MC, Klur S, Watanabe M, Németh AH, Le Ber I, Moniz JC, Tranchant C, Aubourg P, Tazir M, Schöls L, Pandolfo M, Schulz JB, Pouget J, Calvas P, Shizuka-Ikeda M, et al. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nature Genetics. 36: 225-7. PMID 14770181 DOI: 10.1038/ng1303  0.88
2004 Burk K, Globas C, Wahl T, Bühring U, Dietz K, Zuhlke C, Luft A, Schulz JB, Voigt K, Dichgans J. MRI-based volumetric differentiation of sporadic cerebellar ataxia. Brain : a Journal of Neurology. 127: 175-81. PMID 14570820 DOI: 10.1093/brain/awh013  0.88
2003 Seyfried J, Evert BO, Schwarz CS, Schaupp M, Schulz JB, Klockgether T, Wüllner U. Gene dosage-dependent effects of bcl-2 expression on cellular survival and redox status. Free Radical Biology & Medicine. 34: 1517-30. PMID 12788472 DOI: 10.1016/S0891-5849(03)00103-5  0.4
2003 Marx FP, Holzmann C, Strauss KM, Li L, Eberhardt O, Gerhardt E, Cookson MR, Hernandez D, Farrer MJ, Kachergus J, Engelender S, Ross CA, Berger K, Schöls L, Schulz JB, et al. Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. Human Molecular Genetics. 12: 1223-31. PMID 12761037 DOI: 10.1093/Hmg/Ddg134  0.88
2003 Kastrup A, Gröschel K, Krapf H, Brehm BR, Dichgans J, Schulz JB. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke; a Journal of Cerebral Circulation. 34: 813-9. PMID 12624315 DOI: 10.1161/01.Str.0000058160.53040.5F  0.88
2003 von Hörsten S, Schmitt I, Nguyen HP, Holzmann C, Schmidt T, Walther T, Bader M, Pabst R, Kobbe P, Krotova J, Stiller D, Kask A, Vaarmann A, Rathke-Hartlieb S, Schulz JB, et al. Transgenic rat model of Huntington's disease. Human Molecular Genetics. 12: 617-24. PMID 12620967 DOI: 10.1093/Hmg/Ddg075  0.88
2003 Kastrup A, Skalej M, Krapf H, Nägele T, Dichgans J, Schulz JB. Early outcome of carotid angioplasty and stenting versus carotid endarterectomy in a single academic center. Cerebrovascular Diseases (Basel, Switzerland). 15: 84-9. PMID 12499716 DOI: 10.1159/000067134  0.88
2002 Kastrup A, Schulz JB, Mader I, Dichgans J, Küker W. Diffusion-weighted MRI in patients with symptomatic internal carotid artery disease. Journal of Neurology. 249: 1168-74. PMID 12242534 DOI: 10.1007/S00415-002-0793-2  0.88
2002 Simons M, Schwärzler F, Lütjohann D, von Bergmann K, Beyreuther K, Dichgans J, Wormstall H, Hartmann T, Schulz JB. Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial. Annals of Neurology. 52: 346-50. PMID 12205648 DOI: 10.1002/Ana.10292  0.88
2002 Hirrlinger J, Schulz JB, Dringen R. Effects of dopamine on the glutathione metabolism of cultured astroglial cells: implications for Parkinson's disease. Journal of Neurochemistry. 82: 458-67. PMID 12153471 DOI: 10.1046/J.1471-4159.2002.01013.X  0.88
2002 Hirrlinger J, Schulz JB, Dringen R. Glutathione release from cultured brain cells: multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells. Journal of Neuroscience Research. 69: 318-26. PMID 12125073 DOI: 10.1002/Jnr.10308  0.88
2002 Simons M, Kramer EM, Macchi P, Rathke-Hartlieb S, Trotter J, Nave KA, Schulz JB. Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: implications for Pelizaeus-Merzbacher disease. The Journal of Cell Biology. 157: 327-36. PMID 11956232 DOI: 10.1083/jcb.200110138  0.88
2001 Bürk K, Melms A, Schulz JB, Dichgans J. Effectiveness of intravenous immunoglobin therapy in cerebellar ataxia associated with gluten sensitivity. Annals of Neurology. 50: 827-8. PMID 11761488 DOI: 10.1002/ana.1281  0.88
2001 Simons M, Keller P, Dichgans J, Schulz JB. Cholesterol and Alzheimer's disease: is there a link? Neurology. 57: 1089-93. PMID 11571339 DOI: 10.1212/WNL.57.6.1089  0.88
2001 Xia XG, Harding T, Weller M, Bieneman A, Uney JB, Schulz JB. Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 98: 10433-8. PMID 11504916 DOI: 10.1073/Pnas.181182298  0.88
2001 Hirrlinger J, König J, Keppler D, Lindenau J, Schulz JB, Dringen R. The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress. Journal of Neurochemistry. 76: 627-36. PMID 11208926 DOI: 10.1046/J.1471-4159.2001.00101.X  0.88
2000 Eberhardt O, Coelln RV, Kugler S, Lindenau J, Rathke-Hartlieb S, Gerhardt E, Haid S, Isenmann S, Gravel C, Srinivasan A, Bahr M, Weller M, Dichgans J, Schulz JB. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 9126-34. PMID 11124990 DOI: 10.1523/Jneurosci.20-24-09126.2000  0.88
2000 Schulz JB, Dehmer T, Schöls L, Mende H, Hardt C, Vorgerd M, Bürk K, Matson W, Dichgans J, Beal MF, Bogdanov MB. Oxidative stress in patients with Friedreich ataxia. Neurology. 55: 1719-21. PMID 11113228 DOI: 10.1212/Wnl.55.11.1719  0.88
2000 Schulz JB, Lindenau J, Seyfried J, Dichgans J. Glutathione, oxidative stress and neurodegeneration. European Journal of Biochemistry / Febs. 267: 4904-11. PMID 10931172 DOI: 10.1046/j.1432-1327.2000.01595.x  0.88
2000 Abele M, Schulz JB, Bürk K, Topka H, Dichgans J, Klockgether T. Nerve conduction studies in multiple system atrophy. European Neurology. 43: 221-3. PMID 10828652 DOI: 10.1159/000008179  0.88
2000 Dehmer T, Lindenau J, Haid S, Dichgans J, Schulz JB. Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. Journal of Neurochemistry. 74: 2213-6. PMID 10800968 DOI: 10.1046/j.1471-4159.2000.0742213.x  0.88
2000 Robertson GS, Crocker SJ, Nicholson DW, Schulz JB. Neuroprotection by the inhibition of apoptosis. Brain Pathology (Zurich, Switzerland). 10: 283-92. PMID 10764048 DOI: 10.1111/J.1750-3639.2000.Tb00262.X  0.88
2000 Abele M, Schulz JB, Bürk K, Topka H, Dichgans J, Klockgether T. Evoked potentials in multiple system atrophy (MSA). Acta Neurologica Scandinavica. 101: 111-5. PMID 10685858 DOI: 10.1034/j.1600-0404.2000.101002111.x  0.88
1999 Dichgans J, Schulz JB. [Aging in parts? Systemic aging of the nervous system]. Der Nervenarzt. 70: 1072-81. PMID 10637812 DOI: 10.1007/s001150050541  0.88
1999 Schulz JB, Dichgans J. Molecular pathogenesis of movement disorders: are protein aggregates a common link in neuronal degeneration? Current Opinion in Neurology. 12: 433-9. PMID 10555832 DOI: 10.1097/00019052-199908000-00010  0.88
1999 Luft AR, Skalej M, Schulz JB, Welte D, Kolb R, Bürk K, Klockgether T, Voight K. Patterns of age-related shrinkage in cerebellum and brainstem observed in vivo using three-dimensional MRI volumetry. Cerebral Cortex (New York, N.Y. : 1991). 9: 712-21. PMID 10554994 DOI: 10.1093/Cercor/9.7.712  0.4
1999 Soldner F, Weller M, Haid S, Beinroth S, Miller SW, Wüllner U, Davis RE, Dichgans J, Klockgether T, Schulz JB. MPP+ inhibits proliferation of PC12 cells by a p21(WAF1/Cip1)-dependent pathway and induces cell death in cells lacking p21(WAF1/Cip1). Experimental Cell Research. 250: 75-85. PMID 10388522 DOI: 10.1006/excr.1999.4504  0.88
1999 Schulz JB, Skalej M, Wedekind D, Luft AR, Abele M, Voigt K, Dichgans J, Klockgether T. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Annals of Neurology. 45: 65-74. PMID 9894879 DOI: 10.1002/1531-8249(199901)45:1<65::Aid-Art12>3.0.Co;2-1  0.88
1999 Simons M, Beinroth S, Gleichmann M, Liston P, Korneluk RG, MacKenzie AE, Bähr M, Klockgether T, Robertson GS, Weller M, Schulz JB. Adenovirus-mediated gene transfer of inhibitors of apoptosis protein delays apoptosis in cerebellar granule neurons. Journal of Neurochemistry. 72: 292-301. PMID 9886081 DOI: 10.1046/J.1471-4159.1999.0720292.X  0.88
1998 Schulz JB, Weller M, Matthews RT, Heneka MT, Groscurth P, Martinou JC, Lommatzsch J, von Coelln R, Wüllner U, Löschmann PA, Beal MF, Dichgans J, Klockgether T. Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia. Cell Death and Differentiation. 5: 847-57. PMID 10203688 DOI: 10.1038/sj.cdd.4400420  0.88
1998 Yang L, Matthews RT, Schulz JB, Klockgether T, Liao AW, Martinou JC, Penney JB, Hyman BT, Beal MF. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 8145-52. PMID 9763461 DOI: 10.1523/Jneurosci.18-20-08145.1998  0.88
1998 Klockgether T, Skalej M, Wedekind D, Luft AR, Welte D, Schulz JB, Abele M, Bürk K, Laccone F, Brice A, Dichgans J. Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. Brain : a Journal of Neurology. 121: 1687-93. PMID 9762957 DOI: 10.1093/Brain/121.9.1687  0.88
1998 Heneka MT, Löschmann PA, Gleichmann M, Weller M, Schulz JB, Wüllner U, Klockgether T. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide. Journal of Neurochemistry. 71: 88-94. PMID 9648854 DOI: 10.1046/j.1471-4159.1998.71010088.x  0.88
1997 Schulz JB, Matthews RT, Klockgether T, Dichgans J, Beal MF. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Molecular and Cellular Biochemistry. 174: 193-7. PMID 9309687 DOI: 10.1023/A:1006852306789  0.88
1997 Ferrante RJ, Shinobu LA, Schulz JB, Matthews RT, Thomas CE, Kowall NW, Gurney ME, Beal MF. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Annals of Neurology. 42: 326-34. PMID 9307254 DOI: 10.1002/Ana.410420309  0.88
1997 Löschmann PA, Wüllner U, Heneka MT, Schulz JB, Kunow M, Wachtel H, Klockgether T. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease. Synapse (New York, N.Y.). 26: 381-91. PMID 9215597 DOI: 10.1002/(Sici)1098-2396(199708)26:4<381::Aid-Syn6>3.0.Co;2-2  0.88
1997 Bruijn LI, Beal MF, Becher MW, Schulz JB, Wong PC, Price DL, Cleveland DW. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proceedings of the National Academy of Sciences of the United States of America. 94: 7606-11. PMID 9207139 DOI: 10.1073/Pnas.94.14.7606  0.88
1997 Schulz JB, Panahian N, Chen YI, Beal MF, Moskowitz MA, Rosen BR, Jenkins BG. Facilitation of postischemic reperfusion with alpha-PBN: assessment using NMR and Doppler flow techniques. The American Journal of Physiology. 272: H1986-95. PMID 9139987 DOI: 10.1152/AJPHEART.1997.272.4.H1986  1
1997 Ferrante RJ, Schulz JB, Kowall NW, Beal MF. Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra. Brain Research. 753: 157-62. PMID 9125443 DOI: 10.1016/S0006-8993(97)00008-5  1
1997 Weller M, Schulz JB, Wüllner U, Löschmann PA, Klockgether T, Dichgans J. Developmental and genetic regulation of programmed neuronal death. Journal of Neural Transmission. Supplementum. 50: 115-23. PMID 9120412 DOI: 10.1007/978-3-7091-6842-4_12  0.4
1996 Schulz JB, Henshaw DR, MacGarvey U, Beal MF. Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity. Neurochemistry International. 29: 167-71. PMID 8837046 DOI: 10.1016/0197-0186(95)00122-0  1
1996 Kirschner PB, Jenkins BG, Schulz JB, Finkelstein SP, Matthews RT, Rosen BR, Beal MF. NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals. Brain Research. 713: 178-85. PMID 8724989 DOI: 10.1016/0006-8993(95)01513-2  0.88
1996 Wüllner U, Löschmann PA, Schulz JB, Schmid A, Dringen R, Eblen F, Turski L, Klockgether T. Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones. Neuroreport. 7: 921-3. PMID 8724674 DOI: 10.1097/00001756-199603220-00018  0.88
1996 Schulz JB, Matthews RT, Henshaw DR, Beal MF. Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases. Neuroscience. 71: 1043-8. PMID 8684608 DOI: 10.1016/0306-4522(95)00527-7  0.88
1996 Schulz JB, Huang PL, Matthews RT, Passov D, Fishman MC, Beal MF. Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. Journal of Neurochemistry. 67: 430-3. PMID 8667023 DOI: 10.1046/J.1471-4159.1996.67010430.X  0.88
1996 Jenkins BG, Brouillet E, Chen YC, Storey E, Schulz JB, Kirschner P, Beal MF, Rosen BR. Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 450-61. PMID 8621749 DOI: 10.1097/00004647-199605000-00011  0.88
1996 Klockgether T, Zühlke C, Schulz JB, Bürk K, Fetter M, Dittmann H, Skalej M, Dichgans J. Friedreich's ataxia with retained tendon reflexes: molecular genetics, clinical neurophysiology, and magnetic resonance imaging. Neurology. 46: 118-21. PMID 8559357 DOI: 10.1212/Wnl.46.1.118  0.88
1995 Schulz JB, Matthews RT, Beal MF. Role of nitric oxide in neurodegenerative diseases. Current Opinion in Neurology. 8: 480-6. PMID 8845936 DOI: 10.1097/00019052-199512000-00016  0.88
1995 Spieker S, Schulz JB, Petersen D, Fetter M, Klockgether T, Dichgans J. Fixation instability and oculomotor abnormalities in Friedreich's ataxia. Journal of Neurology. 242: 517-21. PMID 8530980 DOI: 10.1007/BF00867423  0.88
1995 Kirschner PB, Henshaw R, Weise J, Trubetskoy V, Finklestein S, Schulz JB, Beal MF. Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 15: 619-23. PMID 7790410 DOI: 10.1038/Jcbfm.1995.76  0.88
1995 Schulz JB, Henshaw DR, Matthews RT, Beal MF. Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity. Experimental Neurology. 132: 279-83. PMID 7789466 DOI: 10.1016/0014-4886(95)90033-0  0.88
1995 Beal MF, Ferrante RJ, Henshaw R, Matthews RT, Chan PH, Kowall NW, Epstein CJ, Schulz JB. 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. Journal of Neurochemistry. 65: 919-22. PMID 7616254  0.88
1995 Schulz JB, Matthews RT, Jenkins BG, Brar P, Beal MF. Improved therapeutic window for treatment of histotoxic hypoxia with a free radical spin trap. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 15: 948-52. PMID 7593355 DOI: 10.1038/Jcbfm.1995.120  0.88
1995 Schulz JB, Henshaw DR, Siwek D, Jenkins BG, Ferrante RJ, Cipolloni PB, Kowall NW, Rosen BR, Beal MF. Involvement of free radicals in excitotoxicity in vivo. Journal of Neurochemistry. 64: 2239-47. PMID 7536809 DOI: 10.1046/J.1471-4159.1995.64052239.X  0.88
1995 Schulz JB, Matthews RT, Muqit MM, Browne SE, Beal MF. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. Journal of Neurochemistry. 64: 936-9. PMID 7530297 DOI: 10.1046/J.1471-4159.1995.64020936.X  0.88
1995 Schulz JB, Beal MF. Neuroprotective effects of free radical scavengers and energy repletion in animal models of neurodegenerative disease. Annals of the New York Academy of Sciences. 765: 100-10; discussion 1. PMID 7486598 DOI: 10.1111/J.1749-6632.1995.Tb16565.X  1
1994 Fetter M, Klockgether T, Schulz JB, Faiss J, Koenig E, Dichgans J. Oculomotor abnormalities and MRI findings in idiopathic cerebellar ataxia. Journal of Neurology. 241: 234-41. PMID 8195823 DOI: 10.1007/BF00863774  0.4
1994 Schulz JB, Klockgether T, Petersen D, Jauch M, Müller-Schauenburg W, Spieker S, Voigt K, Dichgans J. Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. Journal of Neurology, Neurosurgery, and Psychiatry. 57: 1047-56. PMID 8089667 DOI: 10.1136/jnnp.57.9.1047  0.88
1994 Henshaw R, Jenkins BG, Schulz JB, Ferrante RJ, Kowall NW, Rosen BR, Beal MF. Malonate produces striatal lesions by indirect NMDA receptor activation. Brain Research. 647: 161-6. PMID 8069700 DOI: 10.1016/0006-8993(94)91412-5  1
1994 Beal MF, Henshaw DR, Jenkins BG, Rosen BR, Schulz JB. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Annals of Neurology. 36: 882-8. PMID 7998775 DOI: 10.1002/Ana.410360613  1
1994 Klockgether T, Bürk K, Schulz JB, Dichgans J, Wessel K, Auburger G. Absence of SCA1 mutation in idiopathic cerebellar ataxia. Journal of Neurology, Neurosurgery, and Psychiatry. 57: 1439-40. PMID 7964835 DOI: 10.1136/jnnp.57.11.1439-a  0.88
1994 Schulz JB, Beal MF. Mitochondrial dysfunction in movement disorders. Current Opinion in Neurology. 7: 333-9. PMID 7952242  1
1994 Schulz JB, Henshaw DR, Jenkins BG, Ferrante RJ, Kowall NW, Rosen BR, Beal MF. 3-Acetylpyridine produces age-dependent excitotoxic lesions in rat striatum. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 14: 1024-9. PMID 7929644 DOI: 10.1038/Jcbfm.1994.134  1
1994 Brouillet E, Henshaw DR, Schulz JB, Beal MF. Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10. Neuroscience Letters. 177: 58-62. PMID 7824183 DOI: 10.1016/0304-3940(94)90044-2  0.88
1994 Brouillet E, Hyman BT, Jenkins BG, Henshaw DR, Schulz JB, Sodhi P, Rosen BR, Beal MF. Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism. Experimental Neurology. 129: 175-82. PMID 7525331 DOI: 10.1006/Exnr.1994.1159  0.88
1993 Bowling AC, Schulz JB, Brown RH, Beal MF. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. Journal of Neurochemistry. 61: 2322-5. PMID 8245985 DOI: 10.1111/J.1471-4159.1993.Tb07478.X  1
Show low-probability matches.